Tumour model

SK-MEL-5

Melanoma
XenograftIn vitro

SK-MEL-5 cells

Human SK-MEL-5 cells were isolated from the axillary nodes of a patient with metastatic  melanoma.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of SCID-CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.
The mice bearing SK-MEL-5 tumours can be treated by intra-peritoneal, intra-venous, intratumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1:(View PDF)
Tumour growth curve of the SK-MEL-5 cells as xenograft Mean ± SEM (n=9; take rate 100%)

 

Download PDF

Model characteristics

Organism
Human
Tissue of origin
Skin
Pathology
Melanoma
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Skin
Melanoma
XenograftIn vitro
Human
Skin
Amelanotic melanoma
XenograftIn vitro
Human
Skin
Malignant melanoma
XenograftIn vitro
Human
Skin
Melanoma
XenograftIn vitro
Mouse
Skin
Melanoma
SyngeneicIn vitroResistant
Human
Skin
Melanoma
XenograftIn vitro